These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33934959)

  • 1. Short- and long-term outcomes of hepatectomy combined with intraoperative radiofrequency ablation for patients with multiple primarily unresectable colorectal liver metastases: a propensity matching analysis.
    Liu M; Wang K; Wang Y; Bao Q; Wang H; Jin K; Liu W; Xing B
    HPB (Oxford); 2021 Oct; 23(10):1586-1594. PubMed ID: 33934959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
    Bao Q; Wang K; Wang HW; Jin KM; Xing BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term outcomes of radiofrequency ablation combined with hepatectomy compared with hepatectomy alone for colorectal liver metastases.
    Imai K; Allard MA; Castro Benitez C; Vibert E; Sa Cunha A; Cherqui D; Castaing D; Baba H; Adam R
    Br J Surg; 2017 Apr; 104(5):570-579. PubMed ID: 28112813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome for colorectal liver metastases: combining hepatectomy with intraoperative ultrasound guided open microwave ablation versus hepatectomy alone.
    Dai Y; Zhang Y; He W; Peng C; Qiu J; Zheng N; Li H; Liu W; Zheng Y; Li B; Yuan Y; Zou R
    Int J Hyperthermia; 2021; 38(1):372-381. PubMed ID: 33657952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiofrequency ablation versus resection for technically resectable colorectal liver metastasis: a propensity score analysis.
    Wang LJ; Zhang ZY; Yan XL; Yang W; Yan K; Xing BC
    World J Surg Oncol; 2018 Oct; 16(1):207. PubMed ID: 30322402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined ablation and resection (CARe) for resectable colorectal cancer liver Metastases-A propensity score matching study.
    Liu M; Wang Y; Wang K; Bao Q; Wang H; Jin K; Liu W; Yan X; Xing B
    Eur J Surg Oncol; 2023 Sep; 49(9):106931. PubMed ID: 37183048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal liver metastases: surgery versus thermal ablation (COLLISION) - a phase III single-blind prospective randomized controlled trial.
    Puijk RS; Ruarus AH; Vroomen LGPH; van Tilborg AAJM; Scheffer HJ; Nielsen K; de Jong MC; de Vries JJJ; Zonderhuis BM; Eker HH; Kazemier G; Verheul H; van der Meijs BB; van Dam L; Sorgedrager N; Coupé VMH; van den Tol PMP; Meijerink MR;
    BMC Cancer; 2018 Aug; 18(1):821. PubMed ID: 30111304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence and survival following microwave, radiofrequency ablation, and hepatic resection of colorectal liver metastases: A systematic review and network meta-analysis.
    Gavriilidis P; Roberts KJ; de'Angelis N; Aldrighetti L; Sutcliffe RP
    Hepatobiliary Pancreat Dis Int; 2021 Aug; 20(4):307-314. PubMed ID: 34127382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy and targeted therapy for patients with initially unresectable colorectal liver metastases, focusing on conversion hepatectomy and long-term survival.
    Beppu T; Miyamoto Y; Sakamoto Y; Imai K; Nitta H; Hayashi H; Chikamoto A; Watanabe M; Ishiko T; Baba H
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S405-13. PubMed ID: 24570379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatectomy vs radiofrequency ablation for colorectal liver metastasis: a propensity score analysis.
    Lee H; Heo JS; Cho YB; Yun SH; Kim HC; Lee WY; Choi SH; Choi DW
    World J Gastroenterol; 2015 Mar; 21(11):3300-7. PubMed ID: 25805937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes Following Different Thermal Ablation Strategies in Patients with Unresectable Colorectal Liver Metastases.
    Li J; Liu G; Xie X; Zhang D; Zheng R; Yang H; Zhong H; Dai G; Yu J; Liang P
    Radiology; 2023 Aug; 308(2):e223135. PubMed ID: 37581502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the therapeutic efficacy between systemic chemotherapy with and without radiofrequency ablation for colorectal cancer liver metastases: A propensity score matching study.
    Hao W; Jun Z; Yan L; Zhong-Yi Z; Bin-Bin J; Gui-Ju L; Wei Y; Lin S; Kun Y
    Br J Radiol; 2023 Aug; 96(1148):20221195. PubMed ID: 37191629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic resection combined with radiofrequency ablation for initially unresectable colorectal liver metastases after effective chemotherapy is a safe procedure with a low incidence of local recurrence.
    Mima K; Beppu T; Chikamoto A; Miyamoto Y; Nakagawa S; Kuroki H; Okabe H; Hayashi H; Sakamoto Y; Watanabe M; Kikuchi K; Baba H
    Int J Clin Oncol; 2013 Oct; 18(5):847-55. PubMed ID: 22940848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation is beneficial in simultaneous treatment of synchronous liver metastases and primary colorectal cancer.
    Hof J; Joosten HJ; Havenga K; de Jong KP
    PLoS One; 2018; 13(3):e0193385. PubMed ID: 29543821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome after laparoscopic radiofrequency ablation of technically resectable colorectal liver metastases.
    Hammill CW; Billingsley KG; Cassera MA; Wolf RF; Ujiki MB; Hansen PD
    Ann Surg Oncol; 2011 Jul; 18(7):1947-54. PubMed ID: 21399885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic analysis of colorectal liver metastases treated by surgery combined with intraoperative radiofrequency ablation].
    Mao R; Zhao JJ; Bi XY; Zhao H; Li ZY; Huang Z; Zhang YF; Chen X; Hu HJ; Wu XL; Hu XH; Cai JQ
    Zhonghua Wai Ke Za Zhi; 2017 Jul; 55(7):521-527. PubMed ID: 28655081
    [No Abstract]   [Full Text] [Related]  

  • 17. Potential for cure and predictors of long-term survival after radiofrequency ablation for colorectal liver metastases: A 20-years single-center experience.
    Weilert H; Sadeghi D; Lipp M; Oldhafer KJ; Donati M; Stang A
    Eur J Surg Oncol; 2022 Dec; 48(12):2487-2494. PubMed ID: 35718675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeat hepatic resection in patients with colorectal liver metastases.
    Lee H; Choi SH; Cho YB; Yun SH; Kim HC; Lee WY; Heo JS; Choi DW; Jung KU; Chun HK
    World J Gastroenterol; 2015 Feb; 21(7):2124-30. PubMed ID: 25717247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propensity score matching demonstrates similar results for radiofrequency ablation compared to surgical resection in colorectal liver metastases.
    van de Geest TW; van Amerongen MJ; Nierop PMH; Höppener DJ; Grünhagen DJ; Moelker A; Fütterer JJ; Verhoef C; de Wilt JHW
    Eur J Surg Oncol; 2022 Jun; 48(6):1368-1374. PubMed ID: 35078702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection.
    Andreou A; Gloor S; Inglin J; Di Pietro Martinelli C; Banz V; Lachenmayer A; Kim-Fuchs C; Candinas D; Beldi G
    Surg Oncol; 2021 Sep; 38():101631. PubMed ID: 34298267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.